Diligence memo · auto-generated · as of July 2, 2026
EarliTec Diagnostics, Inc.
EarliTec Diagnostics, Inc. looks fair against its niche peers and is quiet on financing cadence.
Businessfiled
EarliTec Diagnostics, Inc. operates in Medical Devices, based in DECATUR.
Sub-sector tags: medical-devices.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
EarliTec Diagnostics, Inc. has raised $27M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).
Largest single filing: $21M on 2024-03-19.
Most recent recorded round closed around 2024-03-19.
Valuation (modeled)modeled
Provath models EarliTec Diagnostics, Inc. at approximately $160M (range $48M–$302M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.00× the median modeled value of Series B Medical Devices companies in 2022–2024 (5 peers) — value vs value, same stage and era. Within the normal band (100% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 25 months.
Last raise 2.3 yr ago; this sector typically re-raises about every 16 months.
Slightly overdue versus sector cadence.
The last round stepped up 3.9× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 90% of Medical Devices peers (233 compared).
Modeled value ranks above 92% of those peers.
Closest niche peers: Proxim Diagnostics Corp, Eximis Surgical Inc., Zenflow, Inc., Htg Molecular Diagnostics, Inc.
Peoplefiled
10 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.